Literature DB >> 12686654

Pure red-cell aplasia due to anti-erythropoietin antibodies.

Kai-Uwe Eckardt, Nicole Casadevall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12686654     DOI： 10.1093/ndt/gfg182

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  23 in total

Review 1.  Immunogenicity of subcutaneously administered therapeutic proteins--a mechanistic perspective.

Authors:  Anas M Fathallah; Richard B Bankert; Sathy V Balu-Iyer
Journal:  AAPS J       Date:  2013-07-16       Impact factor: 4.009

2.  Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty.

Authors:  Melita Buljan; Damir Nemet; Branka Golubic-Cepulic; Goran Bicanic; Branko Tripkovic; Domagoj Delimar
Journal:  Int Orthop       Date:  2011-10-01       Impact factor: 3.075

Review 3.  Antibody engineering to develop new antirheumatic therapies.

Authors:  John D Isaacs
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

Review 4.  Guidelines and recommendations for the management of anaemia in patients with lymphoid malignancies.

Authors:  David H Henry
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Antierythropoietin antibody-induced pure red cell aplasia: posttransplant evolution.

Authors:  Angel Alonso Melgar; Marta Melgosa Hijosa; Rafael Pardo de la Vega; Carmen García Meseguer; Mercedes Navarro Torres
Journal:  Pediatr Nephrol       Date:  2004-05-07       Impact factor: 3.714

Review 6.  State-of-the-art biosimilar erythropoietins in the management of renal anemia: lessons learned from Europe and implications for US nephrologists.

Authors:  Adrian Covic; Ivo Abraham
Journal:  Int Urol Nephrol       Date:  2015-07-30       Impact factor: 2.370

7.  Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient.

Authors:  Parnell Mattison; Kiran Upadhyay; Jennifer E Wilcox; Asha Moudgil; Douglas M Silverstein
Journal:  Pediatr Nephrol       Date:  2010-01-21       Impact factor: 3.714

Review 8.  Epoetin-associated pure red cell aplasia: past, present, and future considerations.

Authors:  June M McKoy; Robin E Stonecash; Denis Cournoyer; Jerome Rossert; Allen R Nissenson; Dennis W Raisch; Nicole Casadevall; Charles L Bennett
Journal:  Transfusion       Date:  2008-05-14       Impact factor: 3.157

9.  Measurement of anti-erythropoiesis-stimulating agent IgG4 antibody as an indicator of antibody-mediated pure red cell aplasia.

Authors:  Dohan K Weeraratne; Andrew J Kuck; Narendra Chirmule; Daniel T Mytych
Journal:  Clin Vaccine Immunol       Date:  2012-10-31

Review 10.  Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.

Authors:  Leopold Grillberger; Thomas R Kreil; Sonia Nasr; Manfred Reiter
Journal:  Biotechnol J       Date:  2009-02       Impact factor: 4.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.